Primary Record
BELNACASAN
- In stock
- 8,188 g
- Purity
- 99.6 %
- CAS
- 273404-37-8
Compound Identifiers & Properties
- CAS
- 273404-37-8
- PubChem CID
- 11398092
- SMILES
- CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl
- Canonical SMILES
- CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C
Names & Synonyms
- BELNACASAN
- VX-765
- 273404-37-8
- belcanasan
- belnacasanum
- Belnacasan (VX-765)
- Belnacasan [USAN]
- Belnacasan (VX765)
- Belnacasan (USAN)
- Belnacasan(VX-765)
- VX-765 hemiketal
- VX765
- vx-765 (Belnacasan)
- Belnacasan [USAN:INN]
- BELNACASAN [INN]
- Belnacasan (USAN/INN)
- RefChem:116925
- C24H33ClN4O6
- UNII-00OLE78529
- D0HK3N
- Belnacasan (VX-765)?
- ARRY-520 HCl
- BELNACASAN [WHO-DD]
- QCR-2
- MFCD11100350
- cc-448
- VX 765
- GTPL9035
- orb1301082
- SCHEMBL3393597
- 00OLE78529
- CHEMBL2107819
- SCHEMBL29379933
- HMR3480
- CHEBI:188567
- DTXSID901017651
- GLXC-90105
- HMS3884B11
- AMY24224
- AOB87376
- ZINC3963010
- s2228
- VRT-43198
- AKOS024464751
- ACN-039814
- CCG-269769
- VRT-043198
- VX-765)
- CID 9892498
- CID11398092
- NCGC00183682-09
- NCGC00183682-10
- NCGC00183682-13
- Second generation ICE inhibitors, Vertex
- (S)-1-((S)-2-(4-amino-3-chlorobenzamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxotetrahydrofuran-3-yl)pyrrolidine-2-carboxamide
- 4CA-1340
- AC-37622
- AS-35159
- FV137735
- BCP0726000319
- 851091-96-8
- AB0035843
- A8238
- V0176
- VX 765, VX765, VX-765, Belnacasan
- Y0257
- J2.556.000K
- N-(4-Amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-L-prolinamide
- A10984
- D10416
- Z-3198
- (2S)-1-[(2S)-2-[(4-amino-3-chlorobenzoyl)amino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide
- A857663
- (2S)-1-[(2S)-2-[(4-amino-3-chlorophenyl)formamido]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide
- Q27075000
- L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-l-valyl-N-((2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl)-
- B0084-307700
- 1-((2S)-2-((4-Amino-3-chlorobenzoyl)amino)-3,3-dimethylbutanoyl)-N-((2R,3S)-2- ethoxy-5-oxo-tetrahydrofuran-3-yl)-l-prolinamide
- 1-[2-(4-amino-3-chloro-benzoylamino)-3,3-dimethyl-butyryl]-pyrrolidine-2-carboxylic acid
- (2S)-1-((2S)-2-((4-amino-3-chlorobenzoyl)amino)-3,3-dimethylbutanoyl)-N-((2R,3S)-2-ethoxy-5-oxooxolan-3-yl)pyrrolidine-2-carboxamide
- (2S)-1-[(2S)-2-[(4-amino-3-chloro-benzoyl)amino]-3,3-dimethyl-butanoyl]-N-[(2R,3S)-2-ethoxy-5-oxo-tetrahydrofuran-3-yl]pyrrolidine-2-carboxamide
- (s)-1-((s)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2r,3s)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide
- (S)-1-((S)-2-1((-(4-amino-3-chloro-phenyl)-methanoyl)-amino)-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide
- (S)-3-((1-((S)-1-((S)-2-((1-(4-amino-3-chlorophenyl)methanoyl)amino)-3,3-dimethyl-butanoyl)pyrrolidin-2yl)methanoyl)amino)-4-oxo-butyric acid
- 1-((2S)-2-((4-AMINO-3-CHLOROBENZOYL)AMINO)-3,3-DIMETHYLBUTANOYL)-N-((2R,3S)-2-ETHOXY-5-OXO-TETRAHYDROFURAN-3-YL)-L-PROLINAMIDE
- 1-((2S)-2-(4-AMINO-3-CHLOROBENZAMIDO)-3,3-DIMETHYLBUTANOYL)-N-((2R,3S)-2-ETHOXY-5-OXOOXOLAN-3-YL)-L-PROLINAMIDE
- 1-(2-((1-(4-Amino-3-chlorophenyl)methanoyl)amino)-3,3-dimethylbutanoyl)pyrrolidine-2-carboxylic acid
- L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-; N-(4-Amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl]-L-prolinamide; Belnacasan; VX 765
- N-(3-Chloro-4-aminobenzoyl)-3-methyl-L-Val-L-Pro-[(2R)-2beta-ethoxy-5-oxotetrahydrofuran-3beta-yl]NH2
- N-(4-amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-((1S)-2-carboxy-1-formylethyl)-L-prolinamide
- N-(4-Amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-L-prolinamide
- VX-765|||(2S)-1-[(2S)-2-[(4-Amino-3-chlorobenzoyl)amino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide